Medical device company specializing in spinal cord stimulation for chronic pain management.
Nevro Corp., a prominent medical device company, focuses on enhancing the quality of life for patients globally who suffer from chronic pain. Specializing in neuromodulation therapies, Nevro is renowned for its flagship product, the Senza spinal cord stimulation system. This innovative platform is grounded in rigorous clinical research and is designed to effectively manage chronic pain by delivering precise electrical pulses to the spinal cord. Additionally, Nevro offers advanced iterations such as the Senza II and Senza Omnia systems, expanding treatment options and enhancing patient outcomes.
Central to Nevro's offerings is its 10 kHz Therapy, which leverages cutting-edge neuromodulation techniques supported by robust clinical evidence. This therapy represents a significant advancement in pain management, providing patients with targeted relief and improved functionality. The company distributes its products through a combination of direct sales operations and a network of sales agents and independent distributors, ensuring broad accessibility to its innovative solutions.
Founded in 2006 and headquartered in Redwood City, California, Nevro Corp. continues to lead the field of neuromodulation through ongoing research and development initiatives. The company's commitment to innovation is driven by a mission to transform the treatment landscape for chronic pain, offering patients and healthcare providers advanced therapeutic options that prioritize effectiveness and patient well-being. With a strong emphasis on scientific rigor and customer-focused support, Nevro remains dedicated to improving the lives of individuals affected by chronic pain worldwide.